Do you want to read an article? Please log in or register.
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group
Multiple Myeloma (MM)
Related content
Multiple Myeloma (MM)
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Blood Cancer J
Mohan M, Monge J, Shah N, Luan D, Forsberg M, Bhatlapenumarthi V, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, D'Souza A, Szabo A, Schinke C, Chakraborty R
doi: 10.1038/s41408-024-01003-z
Multiple Myeloma (MM)
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis
Leuk Lymphoma
Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N
doi: 10.1080/10428194.2024.2446617
Multiple Myeloma (MM)
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
Leuk Lymphoma
Haider I, Leong DP, Louzada M, McCurdy A, Pond GR, Cameron R, Aljama M, Visram A, Wildes TM, Mian H
doi: 10.1080/10428194.2024.2340052
Multiple Myeloma (MM)
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry
Br J Haematol
Ferment B, Lambert J, Caillot D, Lafon I, Karlin L, Lazareth A, Touzeau C, Leleu X, Moya N, Harel S, Perrot A, Bories P, Vincent L, Lamure S, Mohty M, Malard F, Manier S, Yakoub-Agha I, Schiano De Colella JM, Brisou G, Talbot A, Decaux O, Houot R, Le Gouill S, Bigot N, Facon T, Corre J, Moreau P, Arnulf B, Intergroupe Francophone du Myélome
doi: 10.1111/bjh.19505
RECOMMENDED
Central Nervous System Tumors
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Acta Neuropathol Commun
Hickman RA, Miller AM, Holle BM, Jee J, Liu SY, Ross D, Yu H, Riely GJ, Ombres C, Gewirtz AN, Reiner AS, Nandakumar S, Price A, Kaley TJ, Graham MS, Vanderbilt C, Rana S, Hill K, Chabot K, Campos C, Nafa K, Shukla N, Karajannis M, Li B, Berger M, Ladanyi M, Pentsova E, Boire A, Brannon AR, Bale T, Mellinghoff IK, Arcila ME
doi: 10.1186/s40478-024-01846-4
COMMENTED
Genitourinary Cancer
Neoadjuvant Platinum-Based chemotherapy and lymphadenectomy for penile cancer: an international, Multi-Institutional, Real-World study
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
J Natl Cancer Inst
Rose KM, Pham R, Zacharias NM, Ionescu F, Paravathaneni M, Marchetti KA, Sanchez D, Mustasam A, Sandstrom R, Vikram R, Dhillon J, Rao P, Schneider A, Pagliaro L, Alifrangis C, Albersen M, Roussel E, Master VA, Nazha B, Hernandez C, Moses KA, Protzel C, Montgomery J, Angel M, Tobias-Machado M, Spiess PE, Pettaway CA, Chahoud J
doi: 10.1093/jnci/djae034
Multiple Myeloma (MM)
Risk of infections in multiple myeloma. A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
Haematologica
Blimark CH, Carlson K, Day C, Einarsdottir S, Juliusson G, Karma M, Knut-Bojanowska D, Larfors G, Turesson I, Villegas-Scivetti M, Sverrisdóttir I
doi: 10.3324/haematol.2024.285645
SPECIAL REPORT
Breast Cancer
Results of TRODELVY® real-world data
Multiple Myeloma (MM)
Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real-world evidence
Br J Haematol
Hartley-Brown MA, Weisel K, Bitetti J, Carter JA, McNamara S, Purser M, Palumbo A, Richardson PG
doi: 10.1111/bjh.19627